Phibro Animal Health Corp. (PAHC)
37.98
+0.05
(+0.13%)
USD |
NASDAQ |
Oct 15, 16:00
37.93
-0.05
(-0.13%)
After-Hours: 20:00
Phibro Animal Health Cash from Operations (TTM) : 68.95M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.95M |
| March 31, 2026 | 66.13M |
| December 31, 2025 | 93.08M |
| September 30, 2025 | 76.80M |
| June 30, 2025 | 80.12M |
| March 31, 2025 | 87.28M |
| December 31, 2024 | 55.54M |
| September 30, 2024 | 84.02M |
| June 30, 2024 | 87.59M |
| March 31, 2024 | 79.40M |
| December 31, 2023 | 74.25M |
| September 30, 2023 | 40.21M |
| June 30, 2023 | 13.31M |
| March 31, 2023 | -5.354M |
| December 31, 2022 | -5.481M |
| September 30, 2022 | 17.13M |
| June 30, 2022 | 31.65M |
| March 31, 2022 | 33.14M |
| December 31, 2021 | 43.64M |
| September 30, 2021 | 50.43M |
| June 30, 2021 | 48.31M |
| March 31, 2021 | 49.11M |
| December 31, 2020 | 59.44M |
| September 30, 2020 | 64.62M |
| June 30, 2020 | 59.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 70.35M |
| December 31, 2019 | 59.05M |
| September 30, 2019 | 42.32M |
| June 30, 2019 | 47.17M |
| March 31, 2019 | 42.40M |
| December 31, 2018 | 49.55M |
| September 30, 2018 | 66.48M |
| June 30, 2018 | 70.01M |
| March 31, 2018 | 73.47M |
| December 31, 2017 | 87.74M |
| September 30, 2017 | 81.73M |
| June 30, 2017 | 98.38M |
| March 31, 2017 | 111.40M |
| December 31, 2016 | 79.35M |
| September 30, 2016 | 61.07M |
| June 30, 2016 | 37.22M |
| March 31, 2016 | 32.49M |
| December 31, 2015 | 48.54M |
| September 30, 2015 | 48.95M |
| June 30, 2015 | 68.70M |
| March 31, 2015 | 29.50M |
| December 31, 2014 | 8.654M |
| September 30, 2014 | 16.87M |
| June 30, 2014 | -0.712M |
| March 31, 2014 | 25.49M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Globus Medical, Inc. | 910.39M |
| Zoetis, Inc. | 2.887B |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Veru, Inc. | -26.04M |